Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)
Clinical trial NCT05071222 · RECRUITING
Trial details
- NCT number
- NCT05071222
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2041-11-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.